Wound Care Plan

Pyoderma gangrenosum (Diagnosis by exclusion) #2

Last Updated

19 May 2025

Back

Quick Overview

Reference ID Number: TWS-WCP-41

Scope of Practice (ScOP) Designation

Registered Nurse (RN),Enrolled Nurse (EN),Medical Officer

Treatment Goals

The aim for the treatment goal is completely individual. The most common treatments are corticosteroids and calcineurin antagonists (Dissemond et. al., 2023). This patient was severely cardiovascular compromised and had an active infection that was delaying his Transcatheter Aortic Valve Implantation. The decision was made to prioritise his cardiac care over treatment for the Pyoderma gangrenosum (diagnosis by exclusion).

Aim: Stabilise the wound. This is partticularly important as when pyoderma gangrenosum is excised it can precipitate pathergy and create a vicious cycle of the wounds increasing in size.

Reference:
Dissemond, J., Marzano, A.V., Hampton, P.J. and Ortega-Loayza, A.G., 2023. Pyoderma Gangrenosum: treatment options. Drugs, 83(14), pp.1255-1267.

Aim of Dressing

Stabilise the patient's eschar tissue till cardiac treatment was completed.

Frequency of Dressing Change

Everyday

Consult(s) / Diagnostic Test Required

Dermatology review, Punch Biopsies

References

Shopping List

Page Table of Contents

Product Selection Disclaimer:

The wound care products being currently used are a suggestion ONLY. They do not take into account your patient's individual needs which you must assess. No funding from medical companies has been provided and wound care products are chosen on their merit and what is available on the NSW Health State Wound Care Contract. Where an exact brand name product is not available we suggest you review the alternative tab or use another wound care product from its category eg. Hydrofibre